ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure.

February 1, 2002

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

NCI Advisory Group, Other Cancer Meetings

February 24, 1984